CrushSCI.com
125.7Average days
111Median days
2Fastest days
296Longest days
1402025 publications

Paper Review Records

All Paper Review Records

27 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

53 days

Drug–Drug Interaction Assessment of WXFL10203614 With Rifampicin, Itraconazole and Metformin: A Three‐Cohort Phase I Study

Authors
Jinmei Zhou; Mengshuang Gao; Daolei Zhou; Zhiwei Zhang; Huan Zhang; Yu Sun; Huan ZhouShow moreShow less
Affiliations
1. School of Pharmacy Bengbu Medical University Bengbu Anhui China; 2. Clinical Trial Center The First Affiliated Hospital of Bengbu Medical University Bengbu Anhui China; 3. College of Laboratory Medicine Bengbu Medical University Bengbu Anhui China; 4. Zhuohe Pharmaceutical Group Co., Ltd. Wuxi City Jiangsu Province ChinaShow moreShow less
Source PDF DOI Publisher page
194 days

Comparability of Pharmacokinetics, Safety, and Tolerability of Canakinumab Administration With One Injection (200 mg) of Pre‐Filled Syringe or Auto‐Injector Versus Two Injections (150 and 50 mg) of Pre‐Filled Syringe in Healthy Subjects

Authors
Abhijit Chakraborty; Anshu Marathe; Jong Bong Lee; Kari Wiedinger; Britta Zehnpfennig; Carole Schuhler; Simantini Eddy; Michelle QuinlanShow moreShow less
Affiliations
1. Novartis Institutes for Biomedical Research East Hanover NJ USA; 2. Insmed NJ USA; 3. Novartis Pharma AG Basel Switzerland; 4. Novartis Pharmaceuticals Corporation East Hanover NJ USAShow moreShow less
Source PDF DOI Publisher page
145 days

A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants

Authors
Joseph F. Grippo; Anja Pfaff; Zhongli Xu; Isabell Otto; Claus Thielert; Mihaly Imre; Rui Liu; Wantanee Phuapradit; Yazhong Pei; Cuie Chen; Maria Habel; Renfeng Guo; Camilla ChongShow moreShow less
Affiliations
1. InflaRx GmbH Jena Germany; 2. InflaRx Pharmaceuticals, Inc. Ann Arbor MI USAShow moreShow less
Source PDF DOI Publisher page
159 days

A Bioequivalence Study of Two Formulations of Enzalutamide Soft Capsules in Healthy Chinese Male Subjects

Authors
Jianxin Wang; Kai Gu; Mingxuan Zhang; Miao Yu; Pei Zhao; Jing Yu; Xiaohong Guo; Yating Bai; Jie Liu; Xiaoli Wang; Xiaolai YangShow moreShow less
Affiliations
1. School of pharmacy Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China; 2. Department of Pharmacy Gansu Provincial People's Hospital Lanzhou Gansu Province China; 3. Faculty of Health Sciences (FHS) University of Macau Taipa Macau SAR ChinaShow moreShow less
Source PDF DOI Publisher page
2 days

When Clinical Pharmacology Cannot Wait for Complete Data: Reflections Following the 2026 ACCP Annual Meeting

Authors
Amalia M. IssaShow moreShow less
Affiliations
1. Editor‐in‐Chief, Clinical Pharmacology in Drug Development USAShow moreShow less
Source PDF DOI Publisher page
55 days

Fed–Fasted Differences in Clindamycin Hydrochloride Capsule Pharmacokinetics: A Pooled Analysis of Publicly Available China CDE Regulatory Summaries

Authors
Rui Li; Deshuang Yang; Lang Zhao; Zhengyi Cao; Xiaoyu Li; Mengxi YangShow moreShow less
Affiliations
1. Department of Geriatrics China‐Japan Friendship Hospital Chaoyang District Beijing China; 2. Department of Cardiology of Integrated traditional Chinese and Western Medicine China‐Japan Friendship Hospital Chaoyang District Beijing China; 3. Department of Emergency China‐Japan Friendship Hospital Chaoyang District Beijing China; 4. Department of Hematology China‐Japan Friendship Hospital Chaoyang District Beijing China; 5. Jinan Academician Workstation, Shandong Academy of Chinese Medicine, Lixia District Jinan City Shandong Province ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Clinical Pharmacology in Drug Development take to review a manuscript?

As of 2026-11-17, CrushSCI has 27 complete review records for Clinical Pharmacology in Drug Development. The fastest paper went from submission to acceptance in 2 days (When Clinical Pharmacology Cannot Wait for Complete Data: Reflections Following the 2026 ACCP Annual Meeting, received 2026-09-28, accepted 2026-09-30); the slowest took 296 days. The average is 125.7 days and the median is 111 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.